10 CFOs in Medical Devices
Diabetes, epilepsy, orthopedics, surgical robotics and interventional cardiovascular devices are among the businesses these medical device CFOs finance today, at MiniMed, Sequel Med Tech, NeuroPace, Orthofix, OrthAlign, Distalmotion and Cordis. Five held finance roles at Boston Scientific, Medtronic, Zimmer Biomet or Wright Medical, useful for questions on launch budgets, reimbursement and payer relations, or scaling manufacturing.
Professionals to explore
Chad Spooner
LinkedInExperience: Chief Financial Officer · MiniMed
Diabetes device finance questions fit Chad Spooner, Chief Financial Officer at MiniMed since March 2026, after CFO, Medtronic Diabetes at Medtronic (2025 to 2026). Spooner was Chief Financial Officer at BIC (2020 to 2025) and at Slingshot Health (2018 to 2019), and served on the board of Stamford Health (2022 to 2025).
Is this you? Claim your profile and get paid for calls.
Christopher Scully
LinkedInExperience: Former Chief Financial Officer · Cordis
Christopher Scully is CFO of Cordis, an interventional cardiovascular technology company, a seat held since December 2021 after Executive Vice President and Chief Financial Officer at PPD (2018 to 2021). Scully's Pfizer titles include Chief Commercial Officer, Global Established Pharmaceuticals Business (2014 to 2017), Regional President - Europe Established Products (2010 to 2014) and Vice President Finance - Established Products Business Unit (2008 to 2010).
Is this you? Claim your profile and get paid for calls.
Elaine Birkemeyer
LinkedInExperience: Chief Financial Officer · Tactile Medical
Elaine Birkemeyer has been Chief Financial Officer of Tactile Medical since 2023, leading finance, investor relations, revenue cycle and payer relations. Birkemeyer was CFO, Optum Care Solutions at Optum (2021 to 2023), Chief Financial Officer at Rally Health (2020 to 2021) and SVP Finance, Optum at UnitedHealth Group (2014 to 2020), so payer and reimbursement questions are the strongest fit.
Is this you? Claim your profile and get paid for calls.
Ernie Orticerio
LinkedInExperience: Chief Financial Officer · Candela Medical
Candela Medical, a US-based manufacturer of FDA-cleared laser, IPL, RF microneedling and hydro-infusion microdermabrasion devices, has had Ernie Orticerio as Chief Financial Officer since 2019. Orticerio was Chief Financial Officer at Quanterix (2012 to 2019) and V.P. Finance, Corporate Operations at EMD Millipore (2008 to 2011), useful for questions on finance across several device types.
Is this you? Claim your profile and get paid for calls.
Julie Andrews
LinkedInExperience: Chief Financial Officer · Orthofix
At Orthofix, a medical technology company focused on musculoskeletal care and spinal hardware, Julie Andrews has been Chief Financial Officer since 2024. Andrews has been Board Member and Audit Committee Chair at RxSight, Inc. since 2021, and was Chief Financial Officer at Smart Wires Inc. (2021 to 2023) and SVP, Global Finance at Wright Medical (2019 to 2020), a fit for board reporting and audit questions.
Is this you? Claim your profile and get paid for calls.
Kathie Lenzen
LinkedInExperience: Chief Financial Officer · Safeguard Medical
Chief Financial Officer at Safeguard Medical since November 2021 is Kathie Lenzen; the company brings together life-saving products and knowledge of emergency medical skills. Lenzen was VP & General Manager (2021) and Chief Financial Officer (2019 to 2021) at Key Surgical, Chief Financial Officer, SVP Finance & Administration at Xtant Medical (2018 to 2019) and SVP GM Endo Device Operations at ASTORA Women's Health (2015 to 2017).
Is this you? Claim your profile and get paid for calls.
Mark Slicer
LinkedInExperience: Chief Financial Officer · Sequel Med Tech
Since January 2026, Mark Slicer has been Chief Financial Officer at Sequel Med Tech, which provides automated insulin delivery for people with diabetes. Slicer was Chief Financial Officer at Onto Innovation (2022 to 2025) and, at Boston Scientific, SVP & Global Operations CFO (2019 to 2022), SVP & Corporate Controller (2014 to 2019) and Global Vice President, Finance - Endoscopy, Urology and Women's Health (2012 to 2014).
Is this you? Claim your profile and get paid for calls.
Mike Bushlack
LinkedInExperience: Chief Financial Officer · OrthAlign, Inc.
With OrthAlign, Inc. as Chief Financial Officer since 2017, Mike Bushlack works at a company that provides orthopedic surgeons with technology for ASC settings. Bushlack was CFO at PD Instore (2016 to 2017) and Blue Belt Technologies (2015 to 2016), Controller, Respiratory & Monitoring Solutions at Medtronic (2014 to 2015) and VP Finance and Controller at Covidien (Medtronic Minimally Invasive Therapies Group) (2010 to 2014).
Is this you? Claim your profile and get paid for calls.
Patrick F. Williams
LinkedInExperience: Chief Financial Officer · NeuroPace
Financing a neurology device is a good subject for Patrick F. Williams, Chief Financial Officer at NeuroPace since June 2025; its RNS System is an FDA-approved epilepsy device. Williams was Chief Financial Officer at STAAR Surgical (2020 to 2025), and at Sientra, a Tiger Aesthetics Brand, was SVP & General Manager miraDry Business Unit (2018 to 2019) and Chief Financial Officer (2016 to 2018).
Is this you? Claim your profile and get paid for calls.
Tony Collins
LinkedInExperience: Chief Financial Officer · Distalmotion
Tony Collins has held CFO titles at three companies: Distalmotion (since September 2025), Exactech (2022 to 2025) and Xenter (2021 to 2022). Distalmotion makes the DEXTER robotic surgery system. Collins was earlier Group CFO (2019 to 2021) and Vice President, Corporate Controller and Chief Accounting Officer (2015 to 2019) at Zimmer Biomet, useful for questions on controllership and CFO work at device companies.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For reimbursement and payer relations, start with Elaine Birkemeyer; for operations finance at scale, Mark Slicer. Diabetes device questions fit Chad Spooner or Slicer, orthopedics Julie Andrews or Bushlack, surgical robotics Tony Collins, laser devices Ernie Orticerio, aesthetics and neurology Patrick F. Williams, cardiovascular devices Christopher Scully, and emergency medical products Kathie Lenzen.
Questions to take into the conversation
- 01How do you budget a device launch when payer coverage and reimbursement are still pending?
- 02What changes in the finance team when a device maker moves from one product line to manufacturing at scale?
- 03How should a device company's CFO prepare for a carve-out from a larger medtech parent or for a sale?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.